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INTRODUCTION
Toluene diisocyanate (TDI) is a common cause of occupa-
tional asthma worldwide and is the leading cause of occupa-
tional asthma in Korea (1). Although there has been evidence
suggesting involvement of cell-mediated immunity composed
of activated lymphocytes, eosinophils and mast cells (2), a
recent investigation employing immunohistochemical and
induced sputum technology has demonstrated the possible
involvement of activated neutrophil in TDI-induced bron-
choconstriction and IL-8 production was increased after TDI
exposure in the airway selection of TDI-induced asthma
patients (3, 4).
IL-8 has been recognized as a strong chemokine for induc-
ing neutrophil activation and chemotaxis (5). Epithelial cell
was a major source of chemokines, especially IL-8 in response
to exogenous stimuli in asthmatic subjects (6). The chemokine
productions were augmented by pro-inflammatory cytokines
including IL-1 , TNF- and IFN- in vitro culture of epithe-
lial cells (7). To the best of our knowledge, there has been
little data available on TDI-induced IL-8 production from
bronchial epithelial cells and the effect of pro-inflammatory
cytokines on this chemokine production. Therefore, we look
at IL-8 production; a representing chemokine for neutrophil,
from the bronchial epithelial cells with and without TDI-
HSA conjugate incubation and also investigated the effect
of pro-inflammatory cytokines derived from PBMC culture
supernatant of two different donor groups. The effect of dex-
amethasone as a representing anti-inflammatory agent for
asthma treatment was evaluated on this IL-8 production.
MATERIALS AND METHODS
Experimental design
TDI-human serum albumin (HSA) conjugates were pre-
pared as described in the previous report (8). The Beas-2B cell
line, derived from human bronchial epithelium transformed
by an adenovirus 12-SV40 hybrid virus was purchased from
ATCC. Cells were cultured in BEGM medium (Clonetics,
Walkersville, MD, U.S.A.) containing additives such as bovine
pituitary extract, insulin, hydrocortisone, gentamicin at 37℃
with 5% CO2 in humidified air. To observe TDI-induced
response, epithelial cells were incubated with four concen-
trations (0.5 to 500  g/mL) of TDI-HSA conjugate for 24
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Exposure to Toluene Diisocyanate (TDI) Induces IL-8 Production from
Bronchial Epithelial Cells: Effect of Pro-inflammatory Cytokines
This investigation was designed to confirm IL-8 production from human bronchial
epithelial cells with toluene diisocyanate (TDI) exposure and to examine the effects
of pro-inflammatory cytokine and dexamethasone. We cultured Beas-2B, a bronchial
epithelial cell line with TDI-HSA conjugate and compared with those without conju-
gate. IL-8 in the supernatant was measured by ELISA. To evaluate the effect of pro-
inflammatory cytokines, peripheral blood mononuclear cells (PBMC) were collected
from TDI- and non-TDI asthma patients, and were added to the epithelial cell culture.
Dexamethasone or antibodies to TNF- and IL-1 were pre-incubated with PBMC
supernatant. There was a significant production of IL-8 from bronchial epithelial cells
with addition of TDI-HSA conjugate in a dose-dependent manner, which was sig-
nificantly augmented with addition of PBMC supernatant. Higher production of IL-8
was noted with addition of PBMC supernatant from TDI-asthma patients than in those
from non-TDI asthma patients. IL-1 and IL-1 /TFN antibodies were able to sup-
press the IL-8 productions. Pre-treatment of dexamethasone induced dose-depen-
dent inhibition of the IL-8 production. These results suggest that the IL-8 production
from bronchial epithelial cells contribute to neutrophil recruitment occurring in TDI-
induced airway inflammation. IL-1 released from PBMC of TDI-induced asthma
patients may be one of the pro-inflammatory cytokines to enhance IL-8 production.
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hr and compared with those without incubation, and then
the supernatants were collected. Two groups of PBMC donors
were enrolled; for TDI asthma donor, bronchial sensitizations
of 5 patients were confirmed by positive responses on TDI-
bronchoprovocation tests with clear history of work-related
symptoms. For non-TDI asthma donor, 5 patients with aller-
gic asthma sensitive house dust mites were enrolled.
To evaluate the effect of pro-inflammatory cytokine, cells
(5×104 per each well) were cultured with PBMC super-
natant. PBMCs were purified using Ficoll-Paque (Pharma-
cia, Sweden) from five TDI- and five non-TDI asthma sub-
jects and they (2×106 cells) were incubated for 48 hr with
10  g/mL of TDI-HSA conjugate, which was an optimal
concentration for stimulating T Cell in the previous experi-
ment (9). Then, the supernatants were added to the epithe-
lial cell culture. To evaluate the effect of pro-inflammatory
cytokine, IL-1 and TNF- antibodies to IL-1 and TNF-
(anti-IL-1 alone, anti-IL-1 /TNF , and anti-TNF alone,
1  g/mL each, R&D, U.S.A.) were pre-incubated with PBMC
of two groups of the patients for 24 hr, and add to the epithe-
lial cell culture. For inhibition study by dexamethasone, four
concentrations (0, 0.5, 5, 50, 500  g/mL) of dexamethasone
(Daewon Pharmaceutical Co., Korea) were pre-incubated for
24 hr with PBMC supernatant, and the same step was repeat-
ed. The suppressive effect was presented as % inhibition cal-
culated as follows: (100-[IL-8 level preincubated with block-
ing antibody or dexamethasone/IL-8 level preincubated with-
out blocking antibody or dexamethasone]) ×100. The IL-8
level was quantified using a homemade sandwich-type ELISA
as described in our previous report (10). This ELISA had
less than 10% of intra- and inter-assay coefficient variation. 
Statistical analysis
The Mann-Whitney U was applied to evaluate the statis-
tical differences between the data: A p-value of less than 0.05
was regarded as significant.
Fig. 1. TDI-induced IL-8 production from bronchial epithelial cells, Beas-2B without (   ) or with (   ) PBMC supernatant (A). They were com-
pared between two different PBMC donors: TDI-induced asthma (   ) and allergic non-TDI asthma subjects (   ) (B). All values are pre-
sented as mean±S.E.
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Fig. 2. Percent inhibition of IL-8 production from bronchial epithelial cells with addition of dexamethasone (A), and anti-TNF- and anti-IL-
1( B).
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RESULTS
Production of IL-8 from bronchial epithelial cells and
effect of peripheral blood mononuclear cell super-
natant 
IL-8 production was minimal without addition of TDI-
HSA conjugate. However, the IL-8 production was increased
with additions of TDI-HSA conjugate. When PBMC super-
natant stimulated with TDI-HSA conjugate was added to
the epithelial cell culture, the IL-8 production was increased
in a dose-dependent manner. When compared with controls,
IL-8 production was significantly augmented with the addi-
tion of PBMC supernatant from TDI-induced asthma sub-
jects at each concentration of TDI-HSA conjugate (p<0.05,
respectively, Fig. 1A). When IL-8 production was compared
according to two groups of PBMC donors, it tended to be
higher in the TDI asthma than in non-TDI asthma, and
statistical significance was noted at 500  g/mL of TDI-HSA
conjugate incubation (Fig. 1B).
Effect of pro-inflammation cytokines and dexametha-
sone
Pre-incubation of anti-IL-1 , and anti-IL-1 /TNF could
suppress IL-8 productions, while less inhibitions were noted
with anti-TNF as shown in Fig. 2A. Dexamethasone was
able to suppress the IL-8 production in a dose-dependent
manner (Fig. 2B).
DISCUSSION
This study demonstrated that IL-8 production was noted
with TDI-HSA incubation; however, it could stimulate PBMC
to release pro-inflammatory cytokines such as IL-1 , synergy
with anti-TNF- which could augment IL-8 production from
bronchial epithelial cells. IL-8 production was increased more
with additions of PBMC supernatant derived from TDI-asth-
ma subjects than in those from non-TDI asthma. The mecha-
nism that causes TDI to release cytokines directly from epithe-
lial cells is remains to be further investigated. It was suggest-
ed that diisocyanates bind to airway epithelial cell proteins,
and are taken up by epithelial cells, which could lead to air-
way inflammation composing of cytokine production and
cellular activation (11).
Moreover, the mechanisms how TDI could induce pro-
inflammatory cytokinse from PBMC, particularly in TDI-
sensitized patients can not be explained in this study. Some
reports showed evidence indicating activation of lymphocyte
and macrophage to induce cytokine production in response
to TDI-HSA conjugate (9). Our previous study (9) demon-
strated that TDI-HSA conjugate activated T cell to produce
cytokine production including IFN- and IL-4, although
we could not try to detect other proinflammatory cytokines
from them. Chemokine productions including MCP-1 and
TNF from PBMC from isocyanate induced asthma patients
was significantly higher than those of asymptomatic exposed
workers (12). Further studies will be needed to investigate how
TDI stimulates pro-inflammatory cytokines from PBMC,
which may augment chemokine productions from bronchial
epithelial cells. This study also demonstrated incomplete
inhibition of IL-8 production by dexamethasone suggesting
that further mechanisms other than inhibition of NF B
mediate pathway via steroid (13), may be involved in the
regulation of IL-8 production from epithelial cells stimulat-
ed by TDI.
In conclusion, IL-8 production induced by TDI-HSA
conjugate from bronchial epithelial cells may contribute to
neutrophil recruitment into the airway mucosa when exposed
to TDI, which is augmented by pro-inflammatory cytokines
from PBMC of TDI-induced asthma patients.
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